News
TECH
72.66
-0.10%
-0.07
Bio-Techne Declares Quarterly Dividend Amid Merck Transaction
TipRanks · 2d ago
Bio-Techne (TECH) Stock Trades Above Fair Value On Cash Flow Estimates
Simply Wall St · 2d ago
Press Release: BIO-TECHNE DECLARES DIVIDEND
Dow Jones · 2d ago
BIO-TECHNE DECLARES DIVIDEND
PR Newswire · 2d ago
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Beats Revenue Estimates
NASDAQ · 3d ago
Weekly Report: what happened at TECH last week (1026-1030)?
Weekly Report · 4d ago
Bio Techne (TECH) Could Be 3% Overvalued As Recurring Revenue Supports The Story
Simply Wall St · 10/29 05:36
Charles River Laboratories International Inc. Stock Advances 4.2%, Outperforms Market
Dow Jones · 10/28 20:35
Conestoga SMid Cap Composite Q3 2026 Portfolio Activity
Seeking Alpha · 10/28 18:42
Charles River Laboratories International Inc. Stock Rallies 3.4%, Outperforms Peers
Dow Jones · 10/26 20:35
Bio-Techne downgraded to Sell from Buy at Argus
TipRanks · 10/26 18:25
Weekly Report: what happened at TECH last week (1019-1023)?
Weekly Report · 10/26 09:35
What You Need to Know Ahead of Bio-Techne’s Earnings Release
Barchart · 10/26 09:15
1 healthcare stock for long-term investors and 2 we ignore
Barchart · 10/26 03:00
Lennox International Moves Up In Market Cap Rank, Passing Bio-Techne
NASDAQ · 10/21 20:45
Charles River Laboratories International Inc. Stock Advances 9.3%, Outperforms Peers
Dow Jones · 10/21 20:33
Charles River Laboratories International Inc. Stock Advances 5.1%, Outperforms Peers
Dow Jones · 10/20 20:34
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day
MarketWatch · 10/20 20:30
Weekly Report: what happened at TECH last week (1012-1016)?
Weekly Report · 10/19 09:35
What Investors Got Wrong Before Bio-Techne's Rally
Simply Wall St · 10/17 04:41
More
Webull provides a variety of real-time TECH stock news. You can receive the latest news about Bio-Techne Corp through multiple platforms. This information may help you make smarter investment decisions.
About TECH
Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers. This segment also manufactures and sells fully automated multiomic spatial biology instrumentation and advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use.